Article · 23 Jun 2026
Review articlePublished 20 Sep 2021
High Prevalence of Cancer among Carriers of a Truncated Mutation in Ataxia Telangiectasia Gene
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Ataxia Telangiectasia (AT) gene plays an important role in DNA damage response and involved in several cellular signaling pathways. Here we report a high prevalence of cancer among a Druze family of ~1000 members affected with AT living in the same village in North Israel. During the last four decades 16 AT patients were found homozygotes carrying a truncated mutation at position 1339 (C>T) that eliminating the production of AT protein. The high number of patients in this family is due to highly inbred with a large number of consanguineous marriages. Therefore, the relatively high number of members of the family is carriers of this mutation. Moreover, in this family more than 75 cancer patients were diagnosed. Thus, it is possible to postulate that carriers of truncated mutations in AT gene are potentially at increased high risk for developing cancer. AT patients and heterozygous carriers of AT mutations are sensitive to radiation therapy. Therefore, treatment of cancer patients carrying mutated AT gene may avoid the use of radiation therapy and radiomimetic drugs. New medications act on ATM independent pathways should be discovered.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Hereditary Genetics: Current Research.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHereditary Genetics: Current Research
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Eman Fares”
- BylineArticles whose byline prints “Fuad Fares”
